Scribe Therapeutics Investors

22 investors on Angel Roster list Scribe Therapeutics in their portfolio. Most are private equity firms and venture capital firms, the most common stage is Seed and the largest groups are based in the United States, Israel and China.

Investors are matched on the company name in their portfolio, so companies that share the name Scribe Therapeutics can appear together.

Investors listed
22
With verified email
55%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 22 Scribe Therapeutics investors

The most complete profiles first. Showing 22 of 22.

  • David BonitaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more

    Verified email available

  • Geoffrey HsuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Grace GeVerified

    Venture Capital, Investor · United States

    Series BHealth CareRemote Work TechEnterprise SoftwareHR Tech

    Portfolio: Everlaw, OpenSpace, Photomath, Fleetsmith and 73 more

    Verified email available

  • Greg YapVerified

    Venture Capital, Private Equity Firm, Finance Operator · United States

    Series BAdvertisingHealth CareE-commerceCybersecurity

    Portfolio: Everlaw, OpenSpace, Photomath, Fleetsmith and 73 more

    Verified email available

  • John JarveVerified

    Venture Capital, Founder, Private Equity Firm · United States

    SeedPre-SeedAdvertisingHealth CareE-commerceCybersecurity

    Portfolio: ParAccel, Scribe Therapeutics, PowerReviews, Finaplex, Inc. and 12 more

    Verified email available

  • Shawn CarolanVerified

    Venture Capital, Private Equity Firm, Finance Operator · United States

    Series BAdvertisingHealth CareE-commerceCybersecurity

    Portfolio: PlaySpan, Everlaw, OpenSpace, IMVU and 78 more

    Verified email available

  • JeanVerified

    Venture Capital, Private Equity Firm, Finance Operator · United States

    AdvertisingHealth CareE-commerceCybersecurity

    Portfolio: Everlaw, OpenSpace, Photomath, Fleetsmith and 73 more

    Verified email available

  • Jonathan SilversteinVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jonathan WangVerified

    Private Equity Firm · China

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Mark SiegelVerified

    Venture Capital, Private Equity Firm, Finance Operator · United States

    AdvertisingHealth CareE-commerceCybersecurity

    Portfolio: Carbonite, Scribe Therapeutics, Zuli, CHECK and 17 more

    Verified email available

  • Rishi GuptaVerified

    Private Equity Firm · United States

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Carl Gordon

    Venture Capital

    SeedSeries AHealth and Hospital ServicesMedicalPharmaceuticals

    Portfolio: Good Start Genetics, Turning Point Therapeutics, Igenica, Odyssey Therapeutics and 18 more

    Contact details available

  • Carter Neild

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Chau Khuong

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more

    Contact details available

  • Croom Beatty

    Venture Capital, Private Equity Firm, Finance Operator · United States

    Series BAdvertisingHealth CareE-commerceCybersecurity

    Portfolio: Everlaw, OpenSpace, Photomath, Fleetsmith and 74 more

    Contact details available

  • Scotland Stevens

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Tyler Sosin

    Venture Capital, Private Equity Firm, Finance Operator · United States

    Series BAdvertisingHealth CareE-commerceCybersecurity

    Portfolio: Bread, BitPay, Scribe Therapeutics, PillPack and 5 more

    Contact details available

  • Anat Naschitz

    Private Equity Firm · Israel

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Erez Chimovits

    Private Equity Firm · Israel

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • JORDAN ORMONT

    Venture Capital, Private Equity Firm, Finance Operator · United States

    AdvertisingHealth CareE-commerceCybersecurity

    Portfolio: Everlaw, OpenSpace, Photomath, Fleetsmith and 73 more

    Contact details available

  • Steve SloaneVerified

    Venture Capital, Private Equity Firm, Finance Operator · United States

    Series BAdvertisingHealth CareE-commerceCybersecurity

    Portfolio: Scribe Therapeutics, Journy

    Verified email available

  • Naomi Pilosof Ionita

    Venture Capital, Private Equity Firm, Angel/Individual · United States

    AdvertisingHealth CareE-commerceCybersecurity

    Portfolio: Scribe Therapeutics, ClearBrain, mmhmm

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Scribe Therapeutics investors are on Angel Roster?

Angel Roster lists 22 Scribe Therapeutics investors. 12 of them (55%) include a verified email address.

What types of investors are they?

The most common investor types are Private Equity Firms (20), Venture Capital Firms (17) and Finance Operator Investors (10). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Scribe Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (7), Series A (6) and Series B (6).

Where are Scribe Therapeutics investors based?

Most are based in the United States (18), Israel (2) and China (1).

Which companies have Scribe Therapeutics investors backed?

The most-backed portfolio companies among them are Delfi Diagnostics (16), Passage Bio (11), BlossomHill Therapeutics (11), Kinnate Biopharma (11) and MBX Biosciences (11).

How do I contact Scribe Therapeutics investors?

Create a free Angel Roster account to search and filter all 22, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.